Cargando…

Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro

The most common host entry point of human adapted coronaviruses (CoV) including SARS-CoV-2 is through the initial colonization in the nostril and mouth region which is responsible for spread of the infection. Most recent studies suggest that the commercially available oral and nasal rinse products a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Devin S. M., Ho, Joanna, Wills, Savannah, Kawall, Anasha, Sharma, Avini, Chavada, Krishna, Ebert, Maximilian C. C. J. C., Evoli, Stefania, Singh, Ajay, Rayalam, Srujana, Mody, Vicky, Taval, Shashidharamurthy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828865/ https://www.ncbi.nlm.nih.gov/pubmed/35140265 http://dx.doi.org/10.1038/s41598-022-06104-y

Ejemplares similares

Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity
por: Kawall, Anasha, et al.
Publicado: (2023)

Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
por: Mody, Vicky, et al.
Publicado: (2021)

Lipocalin-2 deficiency may predispose to the progression of spontaneous age-related adiposity in mice
por: Meyers, Keya, et al.
Publicado: (2020)

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
por: Klemm, Theresa, et al.
Publicado: (2020)

Novel anti-obesity effects of beer hops compound xanthohumol: role of AMPK signaling pathway
por: Samuels, Janaiya S., et al.
Publicado: (2018)

Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro
por: Sokolinskaya, Elena L., et al.
Publicado: (2022)

Deubiquitinating Activity of the SARS-CoV Papain-Like Protease
por: Barretto, Naina, et al.
Publicado: (2006)

Aloin in Pregnancy
por: Sircir, P. B.
Publicado: (1932)

On the Therapeutics of Aloin
por: Craig, William
Publicado: (1877)

Guggulsterone Activates Adipocyte Beiging through Direct Effects on 3T3-L1 Adipocytes and Indirect Effects Mediated through RAW264.7 Macrophages
por: Miller, Colette N., et al.
Publicado: (2019)

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach
por: Sencanski, Milan, et al.
Publicado: (2022)

Plasma, tissue and urinary levels of aloin in rats after the administration of pure aloin
por: Park, Mi-Young, et al.
Publicado: (2008)

Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes
por: Tan, Jinlin, et al.
Publicado: (2022)

Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and deISGylating activities
por: Mielech, Anna M., et al.
Publicado: (2014)

MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
por: Mielech, Anna M., et al.
Publicado: (2014)

SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
por: Ershov, P. V., et al.
Publicado: (2023)

On Aloin: The Cathartic Principle of the Aloes
Publicado: (1851)

Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease
por: Clasman, Jozlyn R., et al.
Publicado: (2020)

The papain-like protease of avian infectious bronchitis virus has deubiquitinating activity
por: Yu, Liping, et al.
Publicado: (2017)

Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner
por: Ran, Xiang-Hong, et al.
Publicado: (2022)

Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies
por: Ali Dahhas, Mohammed, et al.
Publicado: (2023)

Notes on "Changed Aloin" and the Resin of Aloes
por: Craig, William
Publicado: (1875)

Notes on "Changed Aloin" and the Resin of Aloes
por: Craig, William
Publicado: (1875)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication
por: Bajaj, Teena, et al.
Publicado: (2023)

Sandwich structure Aloin-PVP/Aloin-PVP-PLA/PLA as a wound dressing to accelerate wound healing
por: Li, Weiping, et al.
Publicado: (2022)

STUDIES IN BLOOD COAGULATION : V. THE COAGULATION OF BLOOD BY PROTEOLYTIC ENZYMES (TRYPSIN, PAPAIN)
por: Eagle, Harry, et al.
Publicado: (1937)

Evaluation of anti-infective potencies of formulated aloin A ointment and aloin A isolated from Aloe barbadensis Miller
por: Donkor, Addai-Mensah, et al.
Publicado: (2020)

Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease
por: Békés, Miklós, et al.
Publicado: (2016)

Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Enhancement of Proteolytic Activity of a Thermostable Papain-Like Protease by Structure-Based Rational Design
por: Dutta, Sruti, et al.
Publicado: (2013)

Inhibitors of SARS-CoV-2 PLpro
por: Calleja, Dale J., et al.
Publicado: (2022)

Myricetin exerts its antiviral activity against infectious bronchitis virus by inhibiting the deubiquitinating activity of papain-like protease
por: Peng, Shuwei, et al.
Publicado: (2021)

Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro
por: Große, Maximilian, et al.
Publicado: (2022)

Cytoprotective Effects of Natural Compounds against Oxidative Stress
por: Mehta, Jay, et al.
Publicado: (2018)

The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity
por: Matthews, Krystal, et al.
Publicado: (2014)

Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking
por: Castillo-Campos, Luis, et al.
Publicado: (2023)

PROTEOLYTIC ENZYMES : III. FURTHER STUDIES ON PROTEIN, POLYPEPTIDE, AND OTHER INHIBITORS OF SERUM PROTEINASE, LEUCOPROTEINASE, TRYPSIN, AND PAPAIN
por: Grob, David
Publicado: (1949)

Plant proteolytic enzyme papain abrogates angiogenic activation of human umbilical vein endothelial cells (HUVEC) in vitro
por: Mohr, Thomas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_73ts4u67ca0pt772499ns35bi8